Loading
Mira Pharmaceuticals, Inc. Stock: price and insider trades · United States
US·Mcap US$31.1M
No insider purchase over the last 90 days. The latest, by Aminov Erez, was filed 22 May 2024.
Mira Pharmaceuticals, Inc.: what insiders have been doing
Mira Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Mira Pharmaceuticals, Inc. in twelve months, the latest record being from 3 October 2025.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
9
Thresholds
n/a
Buy Volume
€2M
3 ops. · all time
Sell Volume
€487,185
3 ops. · all time
Who traded when
BuySaleErez Aminov1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.74
Analyst consensus
Income statement
EBITDA-US$10.5M
Net income-US$10.4M0.0% margin
Valuation
P/Book3.3x
Beta1.55
Balance sheet & cash
Market capUS$31.1M
Free Cash Flow-US$4.7M
Profitability & ownership
ROE-184.3%
ROA-112.7%
% insiders30.6%
% institutions5.2%
Last declaration on 3 October 2025
Declarations9 total
2,685,456 sharesCommon StockSEC:0001493152-25-016957:0
22,378 shares@ US$1.35100.0% of flowCommon StockSEC:0001493152-25-016958:0
62,500 shares@ US$1.3749.6% of flowCommon StockSEC:0001641172-25-026388:0
55,410 shares@ US$1.3949.2% of flowCommon StockSEC:0001493152-24-047998:0
200,000 shares@ US$1.9685.0% of flowCommon StockSEC:0001493152-24-034584:0
2,000 shares@ US$1.001.2% of flowCommon StockSEC:0001493152-24-021069:0
Canonical exit: 19 Aug 2024 (T+90)
13,367 shares@ US$5.069515.0% of flowCommon StockSEC:0000897069-23-001850:0
119,048 shares@ US$7.0043.0% of flowCommon StockSEC:0000897069-23-001265:0
Canonical exit: 5 Nov 2023 (T+90)
157,170 shares@ US$7.0057.0% of flowCommon StockSEC:0000897069-23-001091:0
Canonical exit: 31 Oct 2023 (T+90)
9 of 9 declarations
About Mira Pharmaceuticals, Inc.
Mira Pharmaceuticals, Inc. is a company listed on the XNAS market, specializing in the development of innovative pharmaceutical solutions. It focuses on the research and commercialization of drugs for various therapeutic areas.
